The abstract is read at the publisher; the summary is JClub's.
An automated EHR-based frailty index in 509 older adults with newly diagnosed lung, colorectal, or breast cancer on chemotherapy is linked to higher 6-month hospitalization and worse overall survival.
- Why it matters: Clinicians need scalable ways to stratify risk in older patients receiving chemotherapy, where frailty is associated with adverse outcomes but is often difficult to measure routinely.
- What they did: Using EHR data from at least two visits in the prior 2 years, investigators computed an eFI and categorized patients as fit (eFI ≤0.10), pre-frail (0.10–0.21), frail (>0.21), or non-calculable; they compared 3- and 6-month hospitalizations and estimated OS with Kaplan-Meier and Cox regression.
- The result: Six-month hospitalization rose from 24% (fit) to 42% (pre-frail), 62% (frail), and 50% (non-calculable) (P<.0001), while median OS fell from 38 to 23, 17, and 10 months (p<0.0001); adjusted mortality risk was higher for pre-frail (HR 1.7, 95% CI 1.2–2.3), frail (HR 2.0, 95% CI 1.3–3.1), and non-calculable (HR 2.6, 95% CI 1.7–4.0) versus fit.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.